Jan 29 (Reuters) - Prescient Therapeutics Ltd:
* ALL PTX-200 TRIALS NOW OFF CLINICAL HOLD & EITHER CURRENTLY RECRUITING OR IN PROCESS OF GETTING APPROVALS TO START RECRUITMENT​
* ‍FINAL RESULTS FROM PHASE 1B TRIAL OF PTX-200 EXPECTED Q1 2018​ Source text for Eikon: Further company coverage:
 